- This event has passed.
The 2019 Healthcare Economics Summit
July 16 @ 8:00 am - 11:30 am
The 2019 Healthcare Economics Summit
Event Date: July 16th, 8 am – 11:30 am
Venue: Concordia University Wisconsin (12800 N. Lake Shore Dr.)
Hosts: HealthTech MKE, Concordia University, and the Rx Think Tank
CLICK HERE TO REGISTER
The summit will provide insights into dramatic economic and business changes expected in the business of healthcare for the next year and beyond, focusing on efforts to consumerize care and increase transparency generally, and around drug pricing in particular.
Thought leaders will discuss current and trending topics in the economics of healthcare in the United States. The focus will be on cost, access, and quality and how this can be achieved – and what changes could be coming in the next year from both the federal government and from innovators.
Speakers. The Rx Think Tank, Concordia University and HealthTech MKE have assembled leading healthcare thought leaders to discuss the above topics.
Chet Robson DO, MHCDS, FAAFP (Chief Clinical Officer and Enterprise Medical Director, Office of Clinical Integrity Enterprise Medical Director, Walgreens Healthcare Clinics)
Robert Graboyes, PhD (Senior Research Fellow and Healthcare Scholar, Mercatus Center)
Robert Popovian, PharmD, MS (VP of US Government Relations, Pfizer)
Antonio Ciaccia (Director of Government Relations & Public Affairs, Ohio Pharmacists Association)
Allison Oelschlaeger (Chief Data Officer and Director, Centers for Medicare and Medicaid Services (CMS) in the Dept. of HHS)
Jim Tarasovich (South Region CFO, Ascension-Wisconsin)
Will Tesch (CEO, TESCHGlobal)
Topics. What federal legislation or disruptive healthcare delivery business models might be coming in the next year, and what does it mean to consumerize healthcare delivery, while increasing transparency and competition? This year’s summit will explore this topic in three areas:
1. New federal laws that may be implemented in the next year – from consumerization and competition to drug price controls. Both employers (payers) and the general public are frustrated with increasing healthcare costs and drug prices in particular. Pressure for government intervention is strong. But, is that the solution? Politician’s – and in particular the Trump administration – are looking to
respond with new laws with seemingly contradictory aims to (a) increase transparency, competition, and consumerization, and (b) implement drug price controls benchmarked against other countries. Consumerizing healthcare: Hear about the recent HHS plan put forth by the Trump administration, entitled “Reforming America’s Healthcare System through Choice and Competition.” What does it mean to consumerize healthcare by providing choice and competition, and how might this be implemented?
Controlling drug prices: The federal government is considering implementing drug price controls, based on reference-based pricing modeled after that used in Europe. Learn about the “American Patients First” initiative focused on controlling drug prices. Is this the right solution, or will it hinder market forces and decrease America’s dominant role as a healthcare innovator. Speakers will discuss the causes of high drug prices, and the relative roles and perspectives of pharma, PBMs (pharmacy benefit managers) and pharmacies in the supply chain and pricing.
2. A disruptive new way to deliver primary care, in medical homes across the country? While drug prices are being targeted by politicians on both sides of the aisle, they represent only 10-15% of healthcare costs. Hospital care is the larger healthcare expenditure, especially for emergency room care and nursing homes. But, most patients prefer to get their primary care at or close to home for as long and as often as possible, in what is referred to as “medical homes.” One possibility is to deliver this care through pharmacies – perhaps through what is currently the world’s largest healthcare provider, Walgreens. Is this a viable delivery vehicle for primary care, and how might it work? Hear from Walgreens Chief Clinical Officer charged with implementing this paradigm shift.
3. The digital health revolution, enabling consumerization of care. The last year saw the first-ever FDA approved digital therapeutic. Can digital healthcare tools enable the vision of consumerizing care, by empowering patients and front-line providers with information and decision-making power? Hear from HealthTech innovators, providers, and government regulators on the future role of digital health solutions for delivering more convenient, less expensive and effective primary care digitally.